Skip Navigation


Carcinogenesis Advance Access originally published online on June 19, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/8/1361    most recent
bgg092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hu, R.
Right arrow Articles by Kong, A.-N.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, R.
Right arrow Articles by Kong, A.-N.T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 8, 1361-1367, August 2003
© 2003 Oxford University Press


MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells

Rong Hu, Bok Ryang Kim, Chi Chen, Vidya Hebbar and A.-N.Tony Kong1

Department of Pharmaceutics, Ernest-Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA

1 To whom correspondence should be addressed Email: kongt{at}cop.rutgers.edu

Phenethyl isothiocyanate (PEITC) is a potential chemopreventive agent that is present naturally in widely consumed vegetables, especially in watercress. It has been extensively investigated for its anticancer activities against lung, forestomach and esophageal tumorigenesis. Here we investigated the pro-apoptotic effect of PEITC in HT-29 human colorectal carcinoma cell line, and the mechanism of apoptosis induced by PEITC. PEITC-induced apoptosis was determined by DNA fragmentation assay and diamidino-2-phenylindole (DAPI) staining technique. To understand the mechanisms of apoptosis induced by PEITC, we studied the role of caspases, mitochondria-cytochrome c release, and mitogen-activated protein kinase (MAPK) signaling pathways involved in PEITC-induced apoptosis in HT-29 cells. Both the caspase-3 and -9 activities were stimulated by PEITC. The release of cytochrome c from the mitochondrial inter-space was time- and dose-dependent, with a maximal release at 50 µM after 10 h treatment. Three MAPKs [JNK (c-Jun N-terminal kinase), extracellular signal-regulated protein kinase (ERK) and p38 kinase] were activated shortly after PEITC treatment in HT-29 cells. Importantly, the SP600125 compound, an anthrapyrazolone inhibitor of JNK, but not the ERK and p38 inhibitor, suppressed apoptosis induced by PEITC. Similarly, this JNK inhibitor attenuated both cytochrome c release and caspase-3 activation induced by PEITC. In summary, this study shows that PEITC can induce apoptosis in HT-29 cells in a time- and dose-dependent manner via the mitochondria caspase cascade, and the activation of JNK is critical for the initiation of the apoptotic processes. This mechanism of PEITC may play an important role in the killing of cancerous cells and offer a potential mechanism for its anticancer action in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. D. Lu, H.-M. Shen, M. C.M. Chung, and C. N. Ong
Critical role of oxidative stress and sustained JNK activation in aloe-emodin-mediated apoptotic cell death in human hepatoma cells
Carcinogenesis, September 1, 2007; 28(9): 1937 - 1945.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Hu, J. Straub, D. Xiao, S. V. Singh, H.-S. Yang, N. Sonenberg, and J. Vatsyayan
Phenethyl Isothiocyanate, a Cancer Chemopreventive Constituent of Cruciferous Vegetables, Inhibits Cap-Dependent Translation by Regulating the Level and Phosphorylation of 4E-BP1
Cancer Res., April 15, 2007; 67(8): 3569 - 3573.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Zhang, S. Loganathan, I. Humphreys, and S. K. Srivastava
Benzyl Isothiocyanate-Induced DNA Damage Causes G2/M Cell Cycle Arrest and Apoptosis in Human Pancreatic Cancer Cells
J. Nutr., November 1, 2006; 136(11): 2728 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Gout, C. Morin, F. Houle, and J. Huot
Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation.
Cancer Res., September 15, 2006; 66(18): 9117 - 9124.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Li, R. Guo, W. Li, J. Shao, S. Li, K. Zhao, X. Chen, N. Xu, S. Liu, and Y. Lu
A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide
Carcinogenesis, June 1, 2006; 27(6): 1222 - 1231.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Xu, G. Shen, X. Yuan, J.-h. Kim, A. Gopalkrishnan, Y.-S. Keum, S. Nair, and A.-N. T. Kong
ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells
Carcinogenesis, March 1, 2006; 27(3): 437 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. C. Conaway, C.-X. Wang, B. Pittman, Y.-M. Yang, J. E. Schwartz, D. Tian, E. J. McIntee, S. S. Hecht, and F.-L. Chung
Phenethyl Isothiocyanate and Sulforaphane and their N-Acetylcysteine Conjugates Inhibit Malignant Progression of Lung Adenomas Induced by Tobacco Carcinogens in A/J Mice
Cancer Res., September 15, 2005; 65(18): 8548 - 8557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kuntzen, N. Sonuc, E. N. De Toni, C. Opelz, S. R. Mucha, A. L. Gerbes, and S. T. Eichhorst
Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle Arrest
Cancer Res., August 1, 2005; 65(15): 6780 - 6788.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Traka, A. V. Gasper, J. A. Smith, C. J. Hawkey, Y. Bao, and R. F. Mithen
Transcriptome Analysis of Human Colon Caco-2 Cells Exposed to Sulforaphane
J. Nutr., August 1, 2005; 135(8): 1865 - 1872.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Xiao, Y. Zeng, S. Choi, K. L. Lew, J. B. Nelson, and S. V. Singh
Caspase-Dependent Apoptosis Induction by Phenethyl Isothiocyanate, a Cruciferous Vegetable-Derived Cancer Chemopreventive Agent, Is Mediated by Bak and Bax
Clin. Cancer Res., April 1, 2005; 11(7): 2670 - 2679.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. Tseng, E. A. Scott-Ramsay, and M. E. Morris
Dietary Organic Isothiocyanates Are Cytotoxic in Human Breast Cancer MCF-7 and Mammary Epithelial MCF-12A Cell Lines
Experimental Biology and Medicine, September 1, 2004; 229(8): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. K. Srivastava and S. V. Singh
Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells
Carcinogenesis, September 1, 2004; 25(9): 1701 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Hu, V. Hebbar, B.-R. Kim, C. Chen, B. Winnik, B. Buckley, P. Soteropoulos, P. Tolias, R. P. Hart, and A.-N. T. Kong
In Vivo Pharmacokinetics and Regulation of Gene Expression Profiles by Isothiocyanate Sulforaphane in the Rat
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 263 - 271.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Xiao, C. S. Johnson, D. L. Trump, and S. V. Singh
Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells
Mol. Cancer Ther., May 1, 2004; 3(5): 567 - 576.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.